Indegene Limited (NSE:INDGN)

Market Cap	108.52B -20.4%
Revenue (ttm)	32.63B +18.4%
Net Income	4.39B +14.4%
EPS	18.21 +11.5%
Shares Out	240.01M
PE Ratio	24.82
Forward PE	21.87
Dividend	2.00 (0.44%)
Ex-Dividend Date	n/a

Volume	365,342
Average Volume	465,635
Open	454.50
Previous Close	459.20
Day's Range	445.25 - 457.40
52-Week Range	446.15 - 632.90
Beta	n/a
RSI	36.28
Earnings Date	Apr 28, 2026

About Indegene

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technolo...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,158
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In fiscal year 2025, Indegene's revenue was 28.39 billion, an increase of 9.64% compared to the previous year's 25.90 billion. Earnings were 4.07 billion, an increase of 20.79%.